Skip to content

Synaptic density in psychotic disorders

An observational study using the radioligand [11C]-UCB-J for imaging synaptic density in healthy participants, patients with a psychotic disorder and their healthy siblings

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27759
Enrollment
78
Registered
2019-09-25
Start date
2019-10-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, schizoaffective disorder, schizophreniform disorder

Interventions

None listed

Sponsors

Prof. Dr. I.E.C. Sommer
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The participant understands the study and is able to provide written informed consent 2. Must be between the ages of 26-40 3. For patients: must have a diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder 4. For siblings: must have 1 brother or sister with a disorders specified under point 3. The sibling is not necessarily related to one of the participants from the patient group. 5. For controls: participants must be free of any psychiatric or neurological disease and should not have any first- or second-degree relatives with one of the disorders specified under point 3.

Exclusion criteria

Exclusion criteria: 1. Participation in a scientific research study during the past year involving radiation (or exposure to the same amount of ratiation within the past year via other means, e.g., transatlantic flights) 2. MR incompatible implants in the body 3. The possibility of having metal particles in the eyes 4. Tattoo’s containing red pigments that form a safety risk 5. Inability to undergo cognitive testing in Dutch 6. Dangerous or harmful behaviour (i.e. behaviour with a risk of severe physical injury, or actual physical injury inflicted, to self or others) occurred in last 3 months 7. Possibility of pregnancy 8. Intake of levetiracetam or brivaracetam

Design outcomes

Primary

MeasureTime frame
The main study parameter is the relationship between synaptic density and cognitive functioning and the potentially mediating role of functional connectivity in this relationship.

Contacts

Public ContactMonique Germann

University Medical Center Groningen

m.germann@umcg.nl00491633347236

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)